34. TrialReach

Our experts

We are a team of writers, experimenters and researchers providing you with the best advice with zero bias or partiality. This article was authored by:

Founders: Pablo Graiver, Jessica Mann and Eithan Ephratim
Founded: January 2009 (launched Feb 2010)
Website: www.trialreach.com

Entrepreneurial opportunity often exists in making connections: in the case of TrialReach, these connections are between those conducting clinical trials and the patients that could be interested in them. The pharmaceutical industry has traditionally found it a problem to find suitable patients for clinical trials, an issue the three TrialReach founders felt they could address. Using their combined experience in pharmaceuticals and entrepreneurialism, they have built a platform that enables clinicians to connect with patients (who can use the service for free) who want to take part in trials. Pharmaceutical companies and research organisations that have signed up as clients include Novartis, Roche, AstraZeneca, Bristol-Myers Squibb, Nestle, and Parexel with whom TrialReach is working on multiple projects across 25 countries. Ambitions for TrialReach are large, and will be assisted by a recent £2m funding round.

Back to Top